Search Within

Emily A Smith

Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (2)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  3. Biostatistics Service (2)
  4. Center for Hematologic Malignancies (2)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (2)
  6. Center for Pancreatic Cancer Research (2)

More Groups

People
  1. Owen O'connor (10)
  2. Lorraine Toner (9)
  3. Radovan Vrhovac (4)
  4. Jeffrey Gardner (3)
  5. Mark Heaney (3)
  6. David Golde (2)

More People

Years
  1. 2008 (1)
  2. 2006 (2)
  3. 2005 (4)
  4. 2004 (2)
  5. 2003 (2)
Publications
  1. Blood (6)
  2. Clinical Cancer Research (2)
  3. Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (6)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (1)
  4. Taylor & Francis Group (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs
    Journal Article

    Heaney, M. L.; Gardner, J. R.; Karasavvas, N.; Golde, D. W.; Scheinberg, D. A.; Smith, E. A.; O'Connor, O. A.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
    Journal Article

    Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • The combination of the proteasome inhibitor bortezomib and the Bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
    Journal Article

    O'Connor, O. A.; Smith, E. A.; Toner, L. E.; Teruya-Feldstein, J.; Frankel, S.; Rolfe, M.; Wei, X.; Liu, S.; Marcucci, G.; Chan, K. K.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy
    Meeting Abstract

    Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O.
    Blood (2005)

    Fulltext@MSK | Save
  • Oral administration of the opium alkaloid noscapine (NOS) exhibits potent anti-tumor activity against non-Hodgkin's lymphomas and myeloma cell lines in vitro and in vivo in SCID-beige murine xenograft models
    Meeting Abstract

    O'connor, O.; Mastrella, J.; Smith, E.; Toner, L.; Auerbach, A.; Leonard, J. P.
    Blood (2005)

    Fulltext@MSK | Save
  • Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs
    Meeting Abstract

    Heaney, M. L.; Gardner, J. R.; Karasavvas, N.; Golde, D. W.; Scheinberg, D. A.; Smith, E. A.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save
  • Comparative animal models for the study of lymphohematopoietic tumors: Strengths and limitations of present approaches
    Journal Article

    O'Connor, O. A.; Toner, L. E.; Vrhovac, R.; Budak-Alpdogan, T.; Smith, E. A.; Bergman, P.
    Leukemia and Lymphoma (2005)

    Fulltext@MSK | Save
  • A novel antifolate 10-propargyl-10-deazaaminopterin (PDX) displays synergistic effects with gemcitabine in non-Hodgkin's lymphoma models in vitro and in vivo
    Meeting Abstract

    Vrhovac, R.; Toner, L. E.; Smith, E. A.; O'Connor, O. A.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Combined targeting of the proteasome and bcl-2 sensitizes human B-cell lymphoma and multiple myeloma to cyclophosphamide in in vitro and in vivo models of these diseases
    Meeting Abstract

    O'connor, O.; Toner, L.; Smith, E.; Srinivasan, S.; Hernandez, F.; Rolf, M.; Frankel, S.; Chanan-Khan, A.
    Blood (2004)

    Fulltext@MSK | Save
  • A novel antifolate 10-propargyl-10-deazaaminopterin (PDX) displays synergistic effects with gemcitabine in non-Hodgkin's lymphoma models in vitro and in vivo
    Meeting Abstract

    Vrhovac, R.; Toner, L. E.; Smith, E. A.; O'Connor, O. A.
    Blood (2003)

    Fulltext@MSK | Save